Sign in with your email address username.


[Articles] Risk of serious infection in biological treatment of patients with rheumatoid arthritis: a systematic review and meta-analysis

Standard-dose and high-dose biological drugs (with or without traditional DMARDs) are associated with an increase in serious infections in rheumatoid arthritis compared with traditional DMARDs, although low-dose biological drugs are not. Clinicians should discuss the balance between benefit and harm with the individual patient before starting biological treatment for rheumatoid arthritis.